Leonardo Roever: The Emerging Role of the TyHGB Index in Predicting New-Onset Stroke
Leonardo Roever, CEO of Brazilian Evidence-Based Health Network, shared on LinkedIn about a recent article by AoMen Lu and Qian Xu , published in Lipids in Health and Disease, adding:
”Association between the triglyceride-HDL-glucose-body index and the risk of recent-onset stroke: a prospective cohort study
Stroke is a leading cause of mortality and disability in China.
Insulin resistance (IR) is a crucial modifiable risk factor.
Although the triglyceride-glucose (TyG) index is a recognized surrogate marker for IR, it ignores the protective role of HDL cholesterol (HDL-C) and the impact of obesity (BMI).
The new TyHGB index integrates triglycerides, fasting glucose, HDL-C, and BMI, offering a comprehensive metabolic profile.
Long-term elevated patterns and the cumulative burden of the TyHGB index are independent risk factors for recent-onset stroke.
The identification of an inflection point derived from the RCS (25,76) serves as a useful population-level reference value.
The TyHGB index provides incremental value compared to the isolated TyG index in risk stratification, highlighting the importance of dynamic metabolic monitoring for stroke prevention.”
Title: Association between the triglyceride-high-density lipoprotein-glucose-body index and new-onset stroke risk: a prospective cohort study
Authors: AoMen Lu and Qian Xu
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 13, 2026, 20:28Tarun Tyagi: Translational Insights into Severe Immune Thrombocytopenia
-
Jun 13, 2026, 18:25Miguel Gómez Álvarez: Reviewing Inflammation, Transplantation, and Gene Therapy in Hemoglobinopathies
-
Jun 13, 2026, 18:24Ana Pedrero Gil: Why Factor XIII Deficiency Is Often Overlooked During Acute Bleeding
-
Jun 13, 2026, 18:23Tobias Degsell: Building Stronger Bridges Across Disciplines, Countries, and Perspectives at EHA 2026
-
Jun 13, 2026, 18:22Haemoglobinopathies, Innovation, Patient Experience, and Equitable Access at EHA 2026 – TIF
-
Jun 13, 2026, 18:21Thomas Stauch: Discussing the Future of ITP Research and Patient Care
-
Jun 13, 2026, 17:11Kim De Keersmaecker: Advancing Hematology Through Shared Expertise at EHA 2026
-
Jun 13, 2026, 17:03Nour Al-Mozain: The Evolving Role of Apheresis Across Clinical Practice
-
Jun 13, 2026, 16:45Sarah Hendry: A Big Day for Gene Therapy Research at EHA 2026